Key facts
- It has raised $284.4M; the latest was Later Stage VC ($284.4M) in Jan 2026.
- Notable investors include Wuxi Capital, Guotai Junan Innovation Investment, New Alliance Capital, Guanghua Kaiyuan Capital, Shanghai Rui Investment Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Jeyou
- ·The full record, as it builds
Funding rounds
No funding rounds for Jeyou are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jeyou
Manufacturer of innovative pharmaceuticals intended to advance therapies in oncology, nephrology, cardiovascular, respiratory, analgesic, and immunology fields. The company offers comprehensive drug discovery and clinical development capabilities, enabling healthcare providers worldwide to access novel treatments that improve patient outcomes
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2018
- Employees
- 321
- Website
- jeyoupharma.com/
- Ownership
- Privately Held (backing)
Jeyou doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jeyou shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jeyou in its N-PORT filings yet. We sweep new filings monthly.